16 Chapter 1 REFERENCES 1. Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med (2022) 10:447–458. doi: 10.1016/ S2213-2600(21)00511-7 2. Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. Am J Respir Crit Care Med (2017) 195:557–582. doi: 10.1164/RCCM.201701-0218PP 3. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, Cavan D, Shaw JE, Makaroff LE. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract (2017) 128:40–50. doi: 10.1016/j.diabres.2017.03.024 4. Madan S. Changes in Diabetes-Related Complications in the United States. New England Journal of Medicine (2014) 371:284–287. doi: 10.1056/NEJMc1406009 5. Association AD. Diagnosis and classification of diabetes mellitus. Diabetes Care (2009) 32:S62– S67. doi: 10.2337/dc09-S062 6. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. Journal of Clinical Investigation (2005) 115:1111–1119. doi: 10.1172/jci25102 7. Vachharajani V, Granger DN. Adipose tissue: A motor for the inflammation associated with obesity. IUBMB Life (2009) 61:424–430. doi: 10.1002/iub.169 8. Satoh J, Yagihashi S, Toyota T. The Possible Role of Tumor Necrosis Factor-α in Diabetic Polyneuropathy. Exp Diabesity Res (2003) 4:65. doi: 10.1155/EDR.2003.65 9. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance. Science (1979) (1993) 259:87–91. doi: 10.1126/ science.7678183 10. Ginhoux F, Jung S. Monocytes and macrophages: Developmental pathways and tissue homeostasis. Nat Rev Immunol (2014) 14:392–404. doi: 10.1038/nri3671 11. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity (2003) 19:71–82. doi: 10.1016/S1074-7613(03)00174-2 12. Varol C, Mildner A, Jung S. Macrophages: Development and Tissue Specialization. Annu Rev Immunol (2015) 33:643–675. doi: 10.1146/annurev-immunol-032414-112220 13. Patel PS, Buras ED, Balasubramanyam A. The role of the immune system in obesity and insulin resistance. J Obes (2013) 2013: doi: 10.1155/2013/616193 14. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of Monocytes, Macrophages, and Dendritic Cells. http://science.sciencemag.org/ 15. Italiani P, Boraschi D. From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation. Front Immunol (2014) 5: doi: 10.3389/fimmu.2014.00514 16. Murray PJ. Macrophage Polarization. The Annual Review of Physiology is online at (2017) 79:541–66. doi: 10.1146/annurev-physiol-022516-034339 17. Martinez FO, Helming L, Gordon S. Alternative Activation of Macrophages: An Immunologic Functional Perspective. Annu Rev Immunol (2009) 27:451–483. doi: 10.1146/annurev. immunol.021908.132532
RkJQdWJsaXNoZXIy MTk4NDMw